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Abstract Escherichia coli H+-ATPase subunit a is a hydro- 
phobic Fo subunit. To investigate the topology of the subunit in 
the membrane, we prepared site-specific polyclonal antibodies 
against amino-terminal (Ser-3 to Leu-16), middle loop (Lys-167 
to Gin-181), and carboxyl-terminal (Thr-259 to His-271) peptide 
segments. Enzyme-linked immunosorbent assay revealed that 
these antibodies pecifically reacted with subunit a of inside-out 
membrane vesicles, but not with that of right-side-out spher- 
oplasts. Full reactivity appeared when spheroplasts were 
disrupted with Triton X-100 (0.5%) or by sonication. These 
results suggest hat at least parts of the three peptide segments of 
subunit a face the cytoplasm. Based on these observations, we 
propose a novel transmembrane topology of subunit a. 
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Hydrophobic F0 subunit 
To understand the mechanism of H + translocation through 
F0, determination of the transmembrane topology of subunit 
a is necessary. So far, five transmembrane models of subunit 
a, based on the results of hydropathy analysis [5,6,10], pro- 
tease digestion [6], chemical cross-linking [11], location of chi- 
meric fusion protein [12,13], and revertant analysis [14], have 
been proposed. However, there are many discrepancies in the 
orientations and identification of transmembrane segments 
among these models. In this study, we prepared three kinds 
of site-specific polyclonal antibodies against amino- and car- 
boxyl-terminal regions, and a middle loop segment o probe 
more directly the orientation of the subunit in the membrane. 
It was found that these antibodies were equally reactive with 
the a subunit of inside-out membranes but not to that of 
right-side-out vesicle spheroplasts. 
2. Materials and methods 
1. Introduction 
The H+-translocating ATPase (FoF1) of Escherichia coli 
catalyzes ATP synthesis driven by an electrochemical proton 
gradient across the cytoplasmic membrane generated by the 
respiratory chain (for reviews, see [1-4]). The ATPase consists 
of two portions, F1 and F0. The catalytic sector F1 is present 
peripherally on the membrane and has five subunits, a, 15, 7, 8 
and e, while the F0 sector in the membrane has three subunits, 
a, b and c, and functions as a proton channel [1-4]. The a 
subunit (271 amino acid residues), coded by the uncB gene, is 
extremely hydrophobic [5,6]. By analyzing a series of nonsense 
and missense mutants as well as site-directed mutants, it was 
found that the Arg-210, Glu-219, and His-245 residues are 
important for H + translocation as well as the binding of F1 
[1-4], [7 10]. Furthermore, a region between Gln-252 and 
Leu-264 contains essential residues for F0 functions, but seven 
carboxyl-terminal residues (Ser-265 to His-271) are dispensa- 
ble [7,8]. 
2.1. Bacterial strains and preparation of membrane vesicles 
Strain DK8 (AuncB-C, ilv: :Tn 10) lacking the unc operon [15] and 
the same strain harboring a recombinant plasmid, pBWU13 (carrying 
the wild-type unc operon) [16], were mainly used in this study. The 
bacterial cells had the highest membrane ATPase activity so far re- 
ported, in which about 25% of inner membrane proteins corresponded 
to FoF1-ATPase. Almost all the enzyme was incorporated into inner 
membranes with the proper orientation as revealed by electron micro- 
scopy, ATPase activities, ATP-dependent proton pumping and ATP 
synthesis [17]. Thus, the bacterial cell is useful for topological studies 
of FoF1. Strains with nonsense mutations in the a subunit were also 
used: KF24, T rp l l l~end [8]; and KF24A harboring pBB263e, 
Tyr263 ~end [7]. Parent strain (KY7230, wild type) was also used 
[8]. These cells were cultured in a rich medium (L-broth) containing 
50 btg/ml ampicillin, harvested by centrifugation, and suspended in 50 
mM Tris-C1 buffer (pH 8.0) containing 10 mM MgC12, 0.5 mM 
EDTA, 1 mM dithiothreitol, 10% glycerol, 0.2 mM phenylmethylsul- 
fonylfluoride, 5 ~tg/ml leupeptin and 5 I.tg/ml pepstatin A [17]. Inside- 
out membrane vesicles were prepared by passing cells through a 
French press [18]. Spheroplasts (right side-out vesicles) were prepared 
by lysozyme treatment [19], and suspended in phosphate-buffered sal- 
ine comprising 148 mM NaC1, 2.7 mM KCI, 1.5 mM KH2PO4, 8.1 
mM NaHPO4 (pH 7.2) (PBS) containing 20% (w/v) sucrose and 0.1 
mg/ml chloramphenicol. 
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2.2. Preparation of site-specific antibodies 
According to the hydropathy plot of subunit a shown in Fig. 1, the 
following peptides were synthesized and conjugated with keyhole lim- 
pet hemocyanin by the addition of glutaraldehyde [20]: peptide aN 
covering the amino-terminal region, aSENMTPQDTIGHHL; peptide 
aC for the carboxyl-terminal region, 259TIVTLSMASGEEH; and 
peptides aM1 and aM2 for loop regions 87NGSVKDMYHGKSK 
and 167KMKGIGGFTKELTLQ, respectively. Antibodies were raised 
by injecting these antigens emulsified with Freund's complete adjuvant 
into albino rabbits. The antisera (0.5 ml) were diluted 20-fold with 
PBS containing 0.05% Tween 20 (PBS-Tween), and then incubated at 
room temperature for 2 h with nitrocellulose sheets (Toyo Roshi Co., 
Ltd), to which the purified subunit a was electrically transferred. The 
nitrocellulose sheets were washed several times with PBS-Tween, sus- 
pended in 2 ml of 0.1 M glycine-HCl (pH 3.0), and then agitated 
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Fig. 1. Design and preparation of site-specific antibodies against subunit a. (A) Hydropathy plot of subunit a [5,6], and the four different areas 
used for preparation of the antibodies. (B) Immunoblotting of the purified FoF1 (5 pg protein) (lane 1) and inside-out membrane vesicles (100 
I.tg protein) (lane 2) with the purified antibodies at a dilution of 1:500 (for anti-aN and anti-aC) or 1000 (for anti-aM2). The immunological re- 
activity was visualized by means of the peroxidase reaction with 4-chloro-l-naphthol as a substrate. 
vigorously. The solution was immediately neutralized with 1 M Tris, dialyzed against 10 mM (NH4)HCOa for 3 h and used as purified 
and then bovine IgG (100 ~tg) was added. The solution was then antibodies. 
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Fig. 2. Specificity of the antibodies. Microtiter plates were covered with a synthetic peptide (0.5 Ixg) coated with the amino-terminal N (A), 
middle M2 (B), or carboxyl-terminal aC (C) region. Then the plates were washed twice with PBS containing 1% bovine serum albumin. The 
immunoreactivities of the purified antibodies were assayed by ELISA. (• )  Anti-aN; (11) anti-aM2; (o) anti-aC. 
2.3. Measurement of antibody binding to membranes 
For the enzyme-linked immunosorbent assay (ELISA), the antigen 
(0.5 I.tg of synthetic peptide or 0.5 ktg of membrane vesicles in 0.1 ml 
PBS) was incubated in a microtiter plate (type MS-8696F; Sumitomo 
Bakelite Co., Ltd) for 5 h at 4°C. After washing twice with PBS, the 
wells were blocked with PBS containing 1% bovine serum albumin for 
1 h at 25°C. Then, antibodies (50 ng) diluted with PBS-Tween were 
added, followed by incubation for 2 h, and washing four times with 
PBS-Tween. Subsequently, the wells were treated with anti-rabbit IgG 
conjugated with horseradish peroxidase (Organon Teknika Corp.), 
washed several times, and then immunoreactivity was assayed using 
tetramethylbendizine as a substrate (Kirkegaard & Perry Labora- 
tories, Inc.) with an ELISA reader (BioRad). 
2.4. Protease treatment 
Fl-depleted membrane vesicles (5 ktg protein) were incubated in 1 ml 
of 20 mM Tris-C1 (pH 7.4) containing an equal amount of subtilisin 
(Sigma) for 1 h at 37°C, and then washed twice (100000×g, 60 min) 
with PBS containing phenylmethylsulfonyl fluoride. The degree of 
digestion of subunit a was examined by immunoblotting. 
2.5. Other procedures 
Published procedures were used for polyacrylamide g l electrophor- 
esis in the presence of sodium dodecyl sulfate [21], immunoblotting 
[17], purification of FoF1 [17], ATP-dependent H+ transport [17], 
hydrolysis of ATP [17], and depletion of F1 from inside-out mem- 
brane vesicles [18]. 
3. Results and discussion 
3.1. Preparation of  site-directed antibodies against subunit a 
Following repeated boosters of synthetic peptides conju- 
gated with hemocyanin, site-specific antibodies against the 
aN, aC and aM2 regions of subunit a could be raised (Fig. 
1; henceforth referred to as anti-aN, anti-aC, and anti-aM2 
antibodies, respectively). Immunoblotting experiments indi- 
cated that these antibodies pecifically recognized subunit a. 
The specificity of the antibodies was demonstrated by ELISA 
assay, since the antibodies reacted with the peptides used as 
antigens, but not with others (Fig. 2). Furthermore, anti-aN 
antibodies recognized the truncated subunit a with 110 (Trp- 
111 --* end) and 262 (Tyr-263 ~ end) residues from the amino- 
terminus [7], while anti-aC antibodies did not react with these 
fragments (results obtained on Western blotting of mutant 
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Fig. 3. Reactivity of the antibodies to inside-out and Fl-depleted membrane vesicles. Inside-out membrane vesicles were prepared from DK8 
lacking FoF1 (open circles) and the same strain with pBWU13 carrying FoF1 the operon (closed circles). The F1 moiety was depleted from the 
latter membrane vesicles (triangles). Microtiter plates were coated with these vesicles (5 ktg protein), and then the immunological reactivities of 
the purified antibodies were measured by ELISA: (A) anti-aN antibodies; (B) anti-aM2 antibodies; (C) anti-aC antibodies. 
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Fig. 4. Reactivity of the antibodies with spheroplasts. Spheroplasts were prepared from DK8/pBWU13, and suspended in PBS in the presence 
(closed circles) or absence (open circles) of Triton X-100 (0.5%). The microtiter plates were then coated with the vesicles (50 ~tg protein), and 
the immunoreactivities with the purified antibodies were measured by ELISA. (A) Anti-aN antibodies; (B) anti-aM2 antibodies; (C) anti-aC 
antibodies. 
membranes; data not shown). Anti-aM2 antibodies did not 
react with truncated subunit a (Trp-lll--+end), but reacted 
with truncated subunit a (Tyr-263 --* end). Moreover, subtilisin 
treatment of Fl-depleted inside-out membrane vesicles pro- 
duced partially digested subunit a with an apparent molecular 
mass of 22 kDa [22]. Anti-aC and anti-aM2 antibodies recog- 
nized this fragment, while anti-aN antibodies did not (data 
not shown). These results clearly indicate that the anti-aN, 
anti-aC and anti-aM2 antibodies pecifically recognize part 
of the peptide sequences in the subunit. We failed to raise 
antibodies against he aM1 region, even after several series 
of attempts. 
3.2. Topology of subunit a in membrane vesicles 
The reactivities of the antibodies with subunit a in sealed 
membrane vesicles should depend on the locations, inside or 
outside, of the peptide segments. We measured the reactivities 
of the antibodies with inside-out membrane vesicles and right 
side-out spheroplasts. All the antibodies reacted with inside- 
out membrane vesicles (Fig. 3). Inside-out membrane vesicles 
prepared from a FoFl-lacking strain did not show any reac- 
tivity with these antibodies. 
On the other hand, these antibodies did not react with 
spheroplasts (Fig. 4). The reactivities apparently increased 
when spheroplasts were disrupted with Triton X-100 (Fig. 
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Fig. 5. Proposed secondary structure of subunit a. This model proposes ix transmembrane segments (I VI) with amino and carboxyl termini 
exposed to the cytoplasmic surface (IN). The peptides (aN, aM2 and aC) used for this study are shown schematically. Both the amino- and 
carboxyl-terminals arelocated at the cytoplasmic surface. 
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4). Similarly increased reactivity was observed when sphero- 
plasts (5 mg) were sonicated using a Branson sonifier (30 s at 
50% of maximam output) or treated with 1% polyoxyethylene 
9-1auryl ether. These results indicate that antigens for these 
antibodies face the cytoplasm not the periplasm. It is note- 
worthy that the reactivities of the antibodies used in this ex- 
periment did not change on removal of the F1 moiety by 
washing of inside-out membrane vesicles with buffer contain- 
ing EDTA, under these conditions more than 90% of F1 being 
released from the membranes (Fig. 3). The exposed F0 showed 
passive H + translocation i hibited by N,N'-dicyclohexylcar- 
bodiimide, and could bind the purified F1. Essentially the 
same results were obtained with the wild-type strain 
KY7230 (not shown). Binding of the antibodies to inside- 
out membrane vesicles from KY7230 reached about 10% of 
that from DK8/pBWU13 due to the decreased amount of 
FoF1 in KY7230. 
These results uggest that the binding sites of these antibod- 
ies are located at the cytoplasmic face of F0 but different from 
the F1 binding domain. 
3.3. Transmembrane topology of subunit a based on the results 
of immunological studies 
From the above results combined with a hydropathy plot 
(Fig. 1), we propose a novel membrane-spanning model for 
subunit a. The subunit contains ix transmembrane s gments, 
and the amino and carboxyl terminals as well as the aM2 
region face the cytoplasm (Fig. 5). The membrane-spanning 
segments (I-IV in Fig. 5) were postulated from the hydropa- 
thy plot (Fig. 1). This model is apparently similar to those 
proposed by Hermolin et al. [11], and Walker et al. [5], but 
has a completely reversed orientation, since the amino- and 
carboxyl-terminals s well as the aM2 region face the periph- 
eral space in their model. In our model, two of the essential 
residues (Arg-210 and Glu-219) are located in the 5th trans- 
membrane segment and His-245 in the 6th transmembrane 
segment, hese locations being reasonable for the involvement 
of these residues in the proton pathway [7]. Cytoplasmic seg- 
ments (aN, aC and aM2) were accessible to the antibodies, 
suggesting that the two terminal (amino and carboxyl) regions 
and the middle one of the a subunit are exposed to the surface 
of the FoFa assembly. 
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